Dendrimers to treat rheumatoid arthritis

ACS Nano

Volumn 5, Issue 9, 2011, Pages 6779-6785

  Bosch, Xavier ^a  

^a HOSPITAL CLÍNIC   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

BODY FLUIDS; BONE; DENDRIMERS; DRUG DELIVERY; EROSION; MAMMALS; PATHOLOGY;

ANTI-INFLAMMATORIES; BIOLOGICAL BARRIER; BIOLOGICAL THERAPIES; INTRAVENOUS INJECTIONS; OSTEOCLASTOGENESIS; PHOSPHORUS-CONTAINING DENDRIMERS; PRO-INFLAMMATORY CYTOKINES; RHEUMATOID ARTHRITIS;

DISEASES;

DENDRIMER;

ANIMAL; ARTICLE; HUMAN; MOUSE; RHEUMATOID ARTHRITIS;

ANIMALS; ARTHRITIS, RHEUMATOID; DENDRIMERS; HUMANS; MICE;

EID: 80053296188     PISSN: 19360851     EISSN: 1936086X     Source Type: Journal    
DOI: 10.1021/nn203190x     Document Type: Review

References (22)

1. Menjoge, A. R.; Kannan, R. M.; Tomalia, D. A. Dendrimer-Based Drug and Imaging Conjugates: Design Considerations for Nanomedical Applications Drug Discovery Today 2010, 15, 171-185
2. Tomalia, D. A.; Fréchet, J. M. J. Discovery of Dendrimers and Dendritic Polymers: A Brief Historical Perspective J. Polym. Sci., Part A: Polym. Chem. 2002, 40, 2719-2728 (Pubitemid 34838729)
3. Yang, H.; Lopina, S. T. Stealth Dendrimers for Antiarrhythmic Quinidine Delivery J. Mater. Sci. Mater. Med. 2007, 18, 2061-2065 (Pubitemid 47421900)
4. Fruchon, S.; Poupot, M.; Martinet, L.; Turrin, C. O.; Majoral, J. P.; Fournié, J. J.; Caminade, A. M.; Poupot, R. Anti-Inflammatory and Immunosuppressive Activation of Human Monocytes by a Bioactive Dendrimer J. Leukoc. Biol. 2009, 85, 553-562
5. Shaunak, S.; Thomas, S.; Gianasi, E.; Godwin, A.; Jones, E.; Teo, I.; Mireskandari, K.; Luthert, P.; Duncan, R.; Patterson, S. et al. Polyvalent Dendrimer Glucosamine Conjugates Prevent Scar Tissue Formation Nat. Biotechnol. 2004, 22, 977-984 (Pubitemid 39014474)
6. McCarthy, T. D.; Karellas, P.; Henderson, S. A.; Giannis, M.; O'Keefe, D. F.; Heery, G.; Paull, J. R.; Matthews, B. R.; Holan, G. Dendrimers as Drugs: Discovery and Preclinical and Clinical Development of Dendrimer-Based Microbicides for HIV and STI Prevention Mol. Pharm. 2005, 2, 312-318 (Pubitemid 41186407)
7. Supattapone, S.; Nguyen, H. O.; Cohen, F. E.; Prusiner, S. B.; Scott, M. R. Elimination of Prions by Branched Polyamines and Implications for Therapeutics Proc. Natl. Acad. Sci. U.S.A. 1999, 96, 14529-14534 (Pubitemid 30000684)
8. Hayder, M.; Poupot, M.; Baron, M.; Nigon, D.; Turrin, C. O.; Caminade, A. M.; Majoral, J. P.; Eisenberg, R. A.; Fournié, J. J.; Cantagrel, A.; et al. A Phosphorus-Based Dendrimer Targets Inflammation and Osteoclastogenesis in Experimental Arthritis. Sci. Transl. Med. 2011, 3, 81ra35.
9. Chauhan, A. S.; Diwan, P. V.; Jain, N. K.; Tomalia, D. A. Unexpected In Vivo Anti-Inflammatory Activity Observed for Simple, Surface Functionalized Poly(amidoamine) Dendrimers Biomacromolecules 2009, 10, 1195-1202
10. Dernedde, J.; Rausch, A.; Weinhart, M.; Enders, S.; Tauber, R.; Licha, K.; Schirner, M.; Zügel, U.; von Bonin, A.; Haag, R. Dendritic Polyglycerol Sulfates as Multivalent Inhibitors of Inflammation Proc. Natl. Acad. Sci. U.S.A. 2010, 107, 19679-19684
11. Poupot, M.; Griffe, L.; Marchand, P.; Maraval, A.; Rolland, O.; Martinet, L.; L'Faqihi-Olive, F. E.; Turrin, C. O.; Caminade, A. M.; Fournié, J. J. et al. Design of Phosphorylated Dendritic Architectures to Promote Human Monocyte Activation FASEB J. 2006, 20, 2339-2351 (Pubitemid 44953864)
12. Sato, K.; Takayanagi, H. Osteoclasts, Rheumatoid Arthritis, and Osteoimmunology Curr. Opin. Rheumatol. 2006, 18, 419-426 (Pubitemid 44297289)
13. Takayanagi, H. Osteoimmunology: Shared Mechanisms and Crosstalk between the Immune and Bone Systems Nat. Rev. Immunol. 2007, 7, 292-304 (Pubitemid 46480961)
14. McInnes, I. B.; Schett, G. Cytokines in the Pathogenesis of Rheumatoid Arthritis Nat. Rev. Immunol. 2007, 7, 429-442 (Pubitemid 46834849)
15. Takayanagi, H. New Immune Connections in Osteoclast Formation Ann. N.Y. Acad. Sci. 2010, 1192, 117-123
16. Nakae, S.; Saijo, S.; Horai, R.; Sudo, K.; Mori, S.; Iwakura, Y. IL-17 Production from Activated T Cells Is Required for the Spontaneous Development of Destructive Arthritis in Mice Deficient in IL-1 Receptor Antagonist Proc. Natl. Acad. Sci. U.S.A. 2003, 100, 5986-5990 (Pubitemid 36576918)
17. Stoll, J. G.; Yasothan, U. Rheumatoid Arthritis Market Nat. Rev. Drug Discovery 2009, 8, 693-694
18. Klareskog, L.; Catrina, A. I.; Paget, S. Rheumatoid Arthritis Lancet 2009, 373, 659-672
19. Lipsky, P. E. Are New Agents Needed to Treat RA? Nat. Rev. Rheumatol. 2009, 5, 521-522
20. Schwarz, E. M.; Looney, R. J.; Drissi, M. H.; O'Keefe, R. J.; Boyce, B. F.; Xing, L.; Ritchlin, C. T. Autoimmunity and Bone Ann. N.Y. Acad. Sci. 2006, 1068, 275-283 (Pubitemid 43824159)
21. Dalbeth, N.; Pool, B.; Smith, T.; Callon, K. E.; Lobo, M.; Taylor, W. J.; Jones, P. B.; Cornish, J.; McQueen, F. M. Circulating Mediators of Bone Remodeling in Psoriatic Arthritis: Implications for Disordered Osteoclastogenesis and Bone Erosion Arthritis Res. Ther. 2010, 12, R164
22. Szodoray, P; Alex, P.; Chappell-Woodward, C. M.; Madland, T. M.; Knowlton, N.; Dozmorov, I.; Zeher, M.; Jarvis, J. N.; Nakken, B.; Brun, J. G. et al. Circulating Cytokines in Norwegian Patients with Psoriatic Arthritis Determined by a Multiplex Cytokine Array System Rheumatology (Oxford) 2007, 46, 417-425 (Pubitemid 46344652)